I’ve written multiple times about the benefits of using different ranges for Time In Range (see “Targets and Goals“). This is revisiting that topic in light of some recent experimental data. Like many this article has become quite long, but it’s split into sections: Terminology introduction, and choosing a new range based on published study …
I’ve mentioned previously a clinical trial I was involved in running, in which 20 people used AndroidAPS and research YpsoPumps. The next trial is now up and running. It’s called “CLOSE IT” (or sometimes CloseIt or Close-It) which stands for “Closed Loop Open SourcE In Type 1 diabetes”. No in case you’re wondering, I didn’t …
Ever since I wrote about the Anubis project (twice in 2021) I keep getting people assuming that I’m responsible for it. They send me requests for units, instructions as to how to make them themselves, etc. Just to be clear: I was one of the people involved in early testing of the units, and I …
I’ve reported previously about my experiences with insulin timings, including what happens when we go off-label and blend Humalog U100 with Lyumjev U100. I’ve now done another phase of experimentation, with a new data point. And some analysis of why these results might come about. I’ll first rewind a bit and explain that Humalog / …
Medtronic recently announced that they’re discontinuing their 1.8 mL insulin pump reservoirs, leaving only their 3 mL reservoirs. The 1.8 mL reservoir will not be available through NDSS after the 30th of June 2023. History With the Paradigm family of pumps Medtronic usually had two versions of each model. For example the 522 and 722 …
Medtronic’s retiring the 1.8 mL Paradigm reservoirs Read More »
Last year I was interviewed for an episode of the Juicebox Podcast, a T1-focussed podcast from the US. That episode (which Scott titled “APS Wookie“) is now online. We talk at length about a variety of issues: of course including my use of a “fully-closed loop” AID system. So if you want to hear what …